CD116, Human (Mavrilimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD116, Human (Mavrilimumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD116, Human (Mavrilimumab biosimilar)
CloneMavrilimumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 lambda2
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD116 Recombinant Antibody. Mavrilimumab is a human monoclonal antibody[1] that inhibits human granulocyte macrophage colony-stimulating factor receptor (GM-CSF-R). Mavrilimumab was discovered as CAM-3001 by Cambridge Antibody Technology and is being developed by MedImmune, Inc. as an investigational drug for the treatment of rheumatoid arthritis.
Immunogenn/a
Other NamesAnti-CD116 Recombinant Antibody, Research Grade Mavrilimumab, Anti-Human CD116 Recombinant Antibody, CAM-3001, Antibody Drug Analogues, Monoclonal Antibody, YR1227, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1085337-57-0
Catalog #YR1227
Priceplease inquire
Order / More InfoCD116, Human (Mavrilimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.